Clinical Research Facility
West Des Moines, Iowa
We've found
10 trials
at this facility
Cardiology / Vascular Diseases, Otolaryngology Clinical Trial
Updated: 12/31/1969
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
Updated: 12/31/1969
Product Surveillance Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Bradycardia Clinical Trial
Updated: 12/31/1969
Micra Transcatheter Pacing System Post-Approval Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 12/31/1969
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Nasal Polyposis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials